Antibiotic Trial to Combine I.V. and Oral Dosing

By Catherine ShafferStaff Writer

Tuesday, October 1, 2013

Tetraphase Pharmaceuticals Inc., of Watertown, Mass., shared the design of its planned Phase III trial of eravacycline for complicated urinary tract infections (cUTI), due to begin enrolling in late 2013.